Other reports

Consolidated Statement of Changes in Net Equity

For details see Note (34) “Equity”.

€ million

 

Equity capital

 

Capital reserves

 

Retained earnings

 

Gains/losses recognized in equity

 

Equity attributable to share­holders of Merck KGaA, Darmstadt, Germany

 

Non-controlling interests

 

Total equity

Jan. 1, 2021

 

565

 

3,814

 

12,378

 

189

 

16,946

 

71

 

17,017

Profit after tax

 

 

 

3,055

 

 

3,055

 

10

 

3,065

Gains/losses recognized in equity

 

 

 

599

 

1,635

 

2,234

 

5

 

2,239

Comprehensive income

 

 

 

3,653

 

1,635

 

5,289

 

15

 

5,304

Dividend payments

 

 

 

-181

 

 

-181

 

-8

 

-189

Profit transfer to/from E. Merck KG, Darmstadt, Germany, including changes in reserves

 

 

 

-716

 

 

-716

 

 

-716

Transactions with no change of control

 

 

 

 

 

 

 

Change in scope of consolidation/Other

 

 

 

 

 

 

 

Dec. 31, 2021

 

565

 

3,814

 

15,134

 

1,824

 

21,338

 

78

 

21,416

€ million

 

Equity capital

 

Capital reserves

 

Retained earnings

 

Gains/losses recognized in equity

 

Equity attributable to share­holders of Merck KGaA, Darmstadt, Germany

 

Non-controlling interests

 

Total equity

Jan. 1, 2022

 

565

 

3,814

 

15,134

 

1,824

 

21,338

 

78

 

21,416

Profit after tax

 

 

 

3,326

 

 

3,326

 

14

 

3,339

Gains/losses recognized in equity

 

 

 

1,109

 

1,261

 

2,370

 

-2

 

2,368

Comprehensive income

 

 

 

4,435

 

1,261

 

5,696

 

12

 

5,708

Dividend payments

 

 

 

-239

 

 

-239

 

-11

 

-251

Profit transfer to/from E. Merck KG, Darmstadt, Germany, including changes in reserves

 

 

 

-868

 

 

-868

 

 

-868

Transactions with no change of control

 

 

 

 

 

 

 

Change in scope of consolidation/Other

 

 

 

 

 

 

 

Dec. 31, 2022

 

565

 

3,814

 

18,463

 

3,086

 

25,927

 

78

 

26,005

Share this page: